Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
ERJ Open Research|February 19, 2019
European Respiratory Society International Congress, Paris, 2018: highlights from the Clinical AssemblyLowie E G W Vanfleteren, Iñigo Ojanguren, Claire M Nolan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 16, 2020
Profibrotic epithelial TGF-β1 signaling involves NOX4-mitochondria cross talk and redox-mediated activation of the tyrosine kinase FYNCarmen Veith, Milena Hristova, Karamatullah Danyal, et al.
ERJ Open Research|January 18, 2018
European Respiratory Society International Congress 2017: highlights from the Clinical AssemblyNicolas Kahn, Evgeni Mekov, Laura Fregonese, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory StudyManuel Röhrich, Dominik Leitz, Frederik M Glatting, et al.
American Journal of Respiratory and Critical Care Medicine|January 22, 2015
Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung diseaseBenedikt Fritzsching, Zhe Zhou-Suckow, Joanna B Trojanek, et al.
Breathe (Sheffield, England)|June 22, 2018
Early Career Members at the ERS International Congress 2017: highlights from the AssembliesNicolas Kahn, Ioannis Tomos, Vasileios Andrianopoulos, et al.
The European Respiratory Journal|May 9, 2020
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registryJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Respiratory Research|March 17, 2019
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
Respiration; International Review of Thoracic Diseases|August 15, 2025
Osteoprotegerin is elevated in pulmonary fibrosis and associates with IPF progression: a pilot studyHabibie Habibie, Kurnia S S Putri, Carian E Boorsma, et al.
The Lancet. Respiratory Medicine|April 2, 2021
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trialJürgen Behr, Antje Prasse, Michael Kreuter, et al.
Pageof 5